104 related articles for article (PubMed ID: 32093905)
1. Analysis of the radio-pathological factors of triple negative breast cancer and determination of risk profiles.
Sebastián Sebastián C; García Mur C; Gros Bañeres B; Cruz Ciria S; Rosero Cuesta DS; Suñén Amador I
Radiologia (Engl Ed); 2020; 62(5):365-375. PubMed ID: 32093905
[TBL] [Abstract][Full Text] [Related]
2. Imaging and histologic prognostic factors in triple-negative breast cancer and carcinoma in situ as a prognostic factor.
Sebastián Sebastián C; García Mur C; Cruz Ciria S; Rosero Cuesta DS; Gros Bañeres B
Radiologia; 2016; 58(4):283-93. PubMed ID: 27064084
[TBL] [Abstract][Full Text] [Related]
3. Breast parenchymal signal enhancement ratio at preoperative magnetic resonance imaging: association with early recurrence in triple-negative breast cancer patients.
Park VY; Kim EK; Kim MJ; Yoon JH; Moon HJ
Acta Radiol; 2016 Jul; 57(7):802-8. PubMed ID: 26516288
[TBL] [Abstract][Full Text] [Related]
4. Perfusion Parameters on Breast Dynamic Contrast-Enhanced MRI Are Associated With Disease-Specific Survival in Patients With Triple-Negative Breast Cancer.
Park VY; Kim EK; Kim MJ; Yoon JH; Moon HJ
AJR Am J Roentgenol; 2017 Mar; 208(3):687-694. PubMed ID: 28004976
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
[TBL] [Abstract][Full Text] [Related]
6. Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study.
van Roozendaal LM; Smit LHM; Duijsens GHNM; de Vries B; Siesling S; Lobbes MBI; de Boer M; de Wilt JHW; Smidt ML
Breast Cancer Res Treat; 2016 Apr; 156(3):465-472. PubMed ID: 27013474
[TBL] [Abstract][Full Text] [Related]
7. Early Stage Triple-Negative Breast Cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence.
Bae MS; Moon HG; Han W; Noh DY; Ryu HS; Park IA; Chang JM; Cho N; Moon WK
Radiology; 2016 Feb; 278(2):356-64. PubMed ID: 26230976
[TBL] [Abstract][Full Text] [Related]
8. Triple-negative breast carcinoma: heterogeneity in immunophenotypes and pharmacokinetic behavior.
Vilagran Fraguell M; Sentís Crivillé M; del Riego Ferrari J; Andreu Navarro FJ; Dalmau Portulàs E; Planas Roquerols J; Lluïsa Baré M
Radiologia; 2016; 58(1):55-63. PubMed ID: 26433625
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and their effect on outcomes of patients with triple negative breast cancer with or without lymph node involvement.
Sobočan M; Turk M; Čater P; Sikošek NČ; Crnobrnja B; Takač I; Arko D
J Int Med Res; 2020 Mar; 48(3):300060519887259. PubMed ID: 31822139
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancer: Pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrence.
Lee YJ; Youn IK; Kim SH; Kang BJ; Park WC; Lee A
Magn Reson Imaging; 2020 Feb; 66():36-41. PubMed ID: 31785544
[TBL] [Abstract][Full Text] [Related]
11. Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype.
Schmitz AM; Loo CE; Wesseling J; Pijnappel RM; Gilhuijs KG
Breast Cancer Res Treat; 2014 Dec; 148(3):541-51. PubMed ID: 25376743
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
13. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
14. Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients.
Kamiya S; Satake H; Hayashi Y; Ishigaki S; Ito R; Kawamura M; Taoka T; Iwano S; Naganawa S
Breast Cancer; 2022 Jan; 29(1):164-173. PubMed ID: 34529241
[TBL] [Abstract][Full Text] [Related]
15. Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.
Budakoglu B; Altundag K; Aksoy S; Kaplan MA; Ozdemir NY; Berk V; Ozkan M; Algin E; Kandemir N; Dogu GG; Harputluoglu H; Arslan UY; Coskun U; Isikdogan A; Oksuzoglu B
J BUON; 2014; 19(4):872-8. PubMed ID: 25536589
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy.
Bhatti AB; Khan AI; Siddiqui N; Muzaffar N; Syed AA; Shah MA; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(6):2577-81. PubMed ID: 24761867
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 protein product in triple negative breast cancers and relation with clinical and histopathological parameters.
Jasar D; Smichkoska S; Kubelka K; Filipovski V; Petrushevska G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):69-79. PubMed ID: 26076776
[TBL] [Abstract][Full Text] [Related]
18. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological profile of breast cancer from Chhattisgarh India: A single-center hospital-based study.
Srivastava NK; Singh S; Mohanty D; Hussain N
J Family Med Prim Care; 2023 Sep; 12(9):1923-1930. PubMed ID: 38024932
[TBL] [Abstract][Full Text] [Related]
20. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
